Results 171 to 180 of about 11,031 (247)

Lipoxin A<sub>4</sub> levels correlate with severity in a Spanish COVID-19 cohort: potential use of endogenous pro-resolving mediators as biomarkers. [PDF]

open access: yesFront Immunol
Sánchez-García S   +8 more
europepmc   +1 more source

Prognostic impacts of lipoxin A4 in relation to diabetes and insulin resistance in patients with acute myocardial infarction: a prospective study [PDF]

open access: gold
Runzhen Chen   +11 more
openalex   +1 more source

A synergistic multimodality treatment approach to address the key drivers of wound chronicity. [PDF]

open access: yesJ Vasc Surg Venous Lymphat Disord
Lohr JM   +6 more
europepmc   +1 more source

Targeting Inflammatory Imbalance in Chronic Kidney Disease: Focus on Anti-Inflammatory and Resolution Mediators. [PDF]

open access: yesInt J Mol Sci
Rispoli RM   +6 more
europepmc   +1 more source

Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer. [PDF]

open access: yesGut
Soundararajan R   +28 more
europepmc   +1 more source

Dysregulation of lipid mediators in patients with frequent exacerbations of COPD. [PDF]

open access: yesERJ Open Res
Fisk M   +14 more
europepmc   +1 more source

Attenuation of adipose tissue inflammation by pro-resolving lipid mediators.

open access: yesCurr Opin Endocr Metab Res
Clark M, Suur BE, Soták M, Börgeson E.
europepmc   +1 more source

Home - About - Disclaimer - Privacy